R. Douglas Norby, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 17,000 shares at $45.00 ($765K) on 2009-08-24, disclosed to the SEC on 2009-08-25.
Scheduled sale ($765k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALXN | SELL | 2013-05-23 | $4.1M | — | Filing → |
| ALXN | SELL | 2012-12-12 | $2.0M | — | Filing → |
| ALXN | SELL | 2012-03-12 | $2.6M | — | Filing → |